Análisis de impacto presupuestario del implante intravítreo de dexametasona para el tratamiento del edema macular diabético

Cervera, Enrique; Andrés-Nogales, Fernando de; Armadá, Félix; Arias, Luis; Oyagüez, Itziar; Martínez, Concha.
Farm. hosp ; 42(6): 244-250, nov.-dic. 2018. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-174852

Documentos relacionados

  1. Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema.
  2. [Dislocation into the anterior chamber and spontaneous repositioning of a dexamethasone intravitreal implant: a case report].
  3. Efficacy of intravitreal dexamethasone implant for the treatment of macular oedema after pars plana vitrectomy for rhegmatogenous retinal detachment: long-term outcomes.
  4. Stability of dexamethasone sodium phosphate over a 28 day period when added to commercial veterinary wipe and pad products.
  5. Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study.
  6. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
  7. Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions.
  8. Tastes great, less filling! Randomized trial comparing perceived palatability of dexamethasone preparations in children.
  9. [Efficacy and safety of intravitreal dexamethasone implant in diabetic macular edema patients with and without prior vitrectomy: a retrospective cohort study].
  10. VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT IN ROUTINE CLINICAL PRACTICE.